Fluoguide A/S (Nasdaq: Fluo)

Fluoguide A/S (Nasdaq: Fluo) company information, Employees & Contact Information

FluoGuide is a clinical-stage biotech company specializing in precision cancer surgery. Our mission is to improve outcomes for cancer patients by helping surgeons remove cancer more accurately. Our lead product, FG001, has been clinically proven to light up cancer during surgery, guiding more precise removal while preserving healthy tissue. FG001 has shown strong results in brain, head and neck, and lung cancers, and is well-tolerated by patients. Scientific data and clinical experience suggest its broad potential across solid tumor types. Strategic partnerships with surgical equipment manufacturers support integration and wide adoption of FG001 in the operating room. FluoGuide is listed on the Nasdaq First North Growth Market in Stockholm under the ticker symbol "FLUO." For more information about FluoGuide's pipeline, technology, and upcoming events, visit www.fluoguide.com.

Company Details

Employees
12
Founded
-
Address
Titangade 9-13, Copenhagen,capital Region Of Denmark 2200,denmark
Phone
+45 31 31 43 73|
Email
in****@****ide.com
Industry
Biotechnology
Keywords
Ceremedy Aps.
HQ
Copenhagen, Capital Region of Denmark
Looking for a particular Fluoguide A/S (Nasdaq: Fluo) employee's phone or email?

Fluoguide A/s (Nasdaq: Fluo) Questions

News

FluoGuide in Advanced Negotiations on Collaboration Agreement with a World Leading Medical Technology Company - Yahoo Finance

FluoGuide in Advanced Negotiations on Collaboration Agreement with a World Leading Medical Technology Company Yahoo Finance

FluoGuide Receives Positive FDA Feedback on FG001 in High-Grade Glioma - Yahoo Finance

FluoGuide Receives Positive FDA Feedback on FG001 in High-Grade Glioma Yahoo Finance

Invitation to FluoGuide A/S (Nasdaq:FLUO) Webcast on 28 August 2025 - Yahoo Finance

Invitation to FluoGuide A/S (Nasdaq:FLUO) Webcast on 28 August 2025 Yahoo Finance

FluoGuide submits clinical trial application for head and neck cancer treatment - PharmaTimes

FluoGuide submits clinical trial application for head and neck cancer treatment PharmaTimes

FluoGuide Announces FG001 Meets Primary Endpoint in Phase llb Trial in Aggressive Brain Cancer - ACCESS Newswire

FluoGuide Announces FG001 Meets Primary Endpoint in Phase llb Trial in Aggressive Brain Cancer ACCESS Newswire

FluoGuide in Advanced Collaboration Deal Talks for Head, Neck Cancer Surgery - MarketScreener

FluoGuide in Advanced Collaboration Deal Talks for Head, Neck Cancer Surgery MarketScreener

Logo color w pay off - Cision News

Logo color w pay off Cision News

Top Fluoguide A/S (Nasdaq: Fluo) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant